Subcommittee OKs bill requiring coverage for provider-ordered biomarker testing
Mar 12, 2025
Mar 12, 2025
House Bill 484, sponsored by Chairman Martin, was amended and passed by the Insurance Subcommittee to require coverage of provider-ordered biomarker (biomarker) testing for diagnosis and treatment management; supporters said the tests can improve targeted cancer care and reduce long-term costs.
The full story
The Insurance Subcommittee voted 6-0 to pass an amended House Bill 484, which requires coverage of provider-ordered biomarker testing when used for diagnosis, treatment, and ongoing management of conditions, according to the sponsor.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or
Free account
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in →